.webp?width=217&height=60&name=Screenpoint-Med%20(1).webp "Screen Point Medical")
.png)
I tell my story to change yours - with Karin Boxem
Karin Boxem shares her fight with breast cancer and the mission that animates her advocacy.
.png)
ScreenPoint Medical highlights Transpara regulatory clearances
Transpara Detection can be used as decision support, as an independent second reader, to optimize workflow, and more.
.png)
AI increases breast cancer detection – with Dr. Cathy Keller
Dr. Cathy Keller discusses how breast AI is used to improve breast screening accuracy and offers key recommendations for awareness and action.
.png)
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
Transpara Breast AI is the technology of choice for first large-scale RCT in the United States to evaluate the role of AI in breast cancer screening.
.png)
ScreenPoint Medical expands in Spain with SACYL - EUSOBI 2025
ScreenPoint Medical partners with SACYL to bring AI for breast cancer detection to Castilla y León, enhancing screening accuracy and efficiency in Spain.
.png)
As imaging volume increases, breast radiology workflow must adapt
Radiology faces an inflection point. Can systemic solutions, including AI, prioritize both patient outcomes and radiologist well-being?